Europe Antacids Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Europe Antacids Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Europe Antacids Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Europe Antacids Market Regional Analysis

6.2 Europe Antacids Market Revenue 2017-2027 (US$ Million)

6.3 Europe Antacids Market Forecast Analysis

7. Europe Antacids Market Analysis – by Dosage Form

7.1 Tablet

7.1.1 Overview
7.1.2 Tablet: Europe Antacids Market – Revenue and Forecast, 2017-2027 (US$ Million)

7.2 Liquid

7.2.1 Overview
7.2.2 Liquid: Europe Antacids Market – Revenue and Forecast, 2017-2027 (US$ Million)

8. Europe Antacids Market Analysis – by Drug Class

8.1 Proton Pump Inhibitors

8.1.1 Overview
8.1.2 Proton Pump Inhibitors: Europe Antacids Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.2 H2 Antagonist

8.2.1 Overview
8.2.2 H2 Antagonist: Europe Antacids Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.3 Acid Neutralizers

8.3.1 Overview
8.3.2 Acid Neutralizers: Europe Antacids Market – Revenue and Forecast, 2017-2027 (US$ Million)

9. Europe Antacids Market Analysis – by Distribution Channel

9.1 Hospital Pharmacy

9.1.1 Overview
9.1.2 Hospital Pharmacy: Europe Antacids Market – Revenue and Forecast, 2017-2027 (US$ Million)

9.2 Retail Pharmacy

9.2.1 Overview
9.2.2 Retail Pharmacy: Europe Antacids Market – Revenue and Forecast, 2017-2027 (US$ Million)

9.3 Online Pharmacy

9.3.1 Overview
9.3.2 Online Pharmacy : Europe Antacids Market – Revenue and Forecast, 2017-2027 (US$ Million)

10. Europe Antacids Market – Europe Analysis

10.1 Overview

10.2 Europe

10.2.1 Europe Antacids Market Breakdown, by Key Country, 2020 and 2027 (%)
10.2.1.1 Europe Antacids Market – Revenue and Forecast Analysis – by Country
10.2.1.1 UK: Europe Antacids Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.1.1 UK: Europe Antacids Market Breakdown, by Dosage Form
10.2.1.1.2 UK: Europe Antacids Market Breakdown, by Drug Class
10.2.1.1.3 UK: Europe Antacids Market Breakdown, by Distribution Channel

10.2.1.2 Germany: Europe Antacids Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.2.1 Germany: Europe Antacids Market Breakdown, by Dosage Form
10.2.1.2.2 Germany: Europe Antacids Market Breakdown, by Drug Class
10.2.1.2.3 Germany: Europe Antacids Market Breakdown, by Distribution Channel

10.2.1.3 France: Europe Antacids Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.3.1 France: Europe Antacids Market Breakdown, by Dosage Form
10.2.1.3.2 France: Europe Antacids Market Breakdown, by Drug Class
10.2.1.3.3 France: Europe Antacids Market Breakdown, by Distribution Channel

10.2.1.4 Russia: Europe Antacids Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.4.1 Russia: Europe Antacids Market Breakdown, by Dosage Form
10.2.1.4.2 Russia: Europe Antacids Market Breakdown, by Drug Class
10.2.1.4.3 Russia: Europe Antacids Market Breakdown, by Distribution Channel

10.2.1.5 Italy: Europe Antacids Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.5.1 Italy: Europe Antacids Market Breakdown, by Dosage Form
10.2.1.5.2 Italy: Europe Antacids Market Breakdown, by Drug Class
10.2.1.5.3 Italy: Europe Antacids Market Breakdown, by Distribution Channel

10.2.1.6 Rest of Europe: Europe Antacids Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.6.1 Rest of Europe: Europe Antacids Market Breakdown, by Dosage Form
10.2.1.6.2 Rest of Europe: Europe Antacids Market Breakdown, by Drug Class
10.2.1.6.3 Rest of Europe: Europe Antacids Market Breakdown, by Distribution Channel

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 Bayer AG

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 GlaxoSmithKline plc

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Takeda Pharmaceutical Company Limited

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Sun Pharmaceutical Industries Ltd

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Sanofi

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Boehringer Ingelheim International GmbH

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Dr. Reddy's Laboratories

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Pfizer Inc

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Reckitt Benckiser Group Plc

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Procter & Gamble

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

Europe Antacids Market

Analysis By Dosage Form (Tablet, Liquid, and Others); Drug Class (Proton Pump Inhibitors, H2 Antagonist, and Acid Neutralizers); Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy)